Find A Portfolio/Ticker
Comparison Box
MyPlanIQ
401k Investor
LEXICON PHARMACEUTICALS INC. 401 K PLAN
LEXICON PHARMACEUTICALS INC. 401 K PLAN Strategic Asset Allocation - Optimal Moderate
LEXICON PHARMACEUTICALS INC. 401 K PLAN Strategic Asset Allocation - Optimal Moderate
live (public) 0.76% December 31
Delayed
Holdings (As of 11/30/2018)
sign up and login first and then customize a new portfolio for the latest current holdings
Asset | Fund in this portfolio | Price change* | Original Fund Description | Percentage |
---|---|---|---|---|
General Bond | FBIDX (FIDELITY U.S. BOND INDEX FUND INVESTOR CLASS) | 0.0% | Fidelity U.S. Bond Index Fund | 20.69% |
US Equity | FDCAX (FIDELITY CAPITAL APPRECIATION FUND FIDELITY CAPITAL APPRECIATION FUND) | 0.15% | Fidelity Capital Appreciation | 20.98% |
US Equity | FDSCX (FIDELITY STOCK SELECTOR SMALL CAP FUND FIDELITY STOCK SELECTOR SMALL CAP FUND) | 0.34% | Fidelity Stock Selector Small Cap Fund | 21.05% |
CASH | CASH (CASH) | 0.0% | CASH | 0.93% |
International Equity | FDIVX (FIDELITY DIVERSIFIED INTERNATIONAL FUND FIDELITY DIVERSIFIED INTERNATIONAL FUND) | 0.65% | FID DIVERSIFD INTL | 8.78% |
International Equity | FSIVX (FIDELITY INTERNATIONAL INDEX FUND PREMIUM CLASS) | 0.72% | SPTN INTL INDEX ADV | 9.04% |
Long Term Bond | PLGBX (LONG-TERM U.S. GOVERNMENT FUND ADMINISTRATIVE) | 0.17% | PIMCO LT US GOVT ADM | 4.08% |
Inflation Protected Bond | APISX (SHORT DURATION INFLATION PROTECTION BOND FUND R5 CLASS) | 0.0% | American Century Inflation-Adjusted BD Fund | 14.45% |
REINVEST | FOCPX (FIDELITY OTC PORTFOLIO FIDELITY OTC PORTFOLIO) | 0.31% | Fidelity OTC Portfolio | 0.79% |
* Day change on 09/28/2018.

Beta
Performance (As of 12/31/2018)
Since 12/31/2000
Name | YTD* Return |
1Yr AR** |
3Yr AR** |
5Yr AR** |
10Yr AR** |
15Yr AR** |
---|---|---|---|---|---|---|
LEXICON PHARMACEUTICALS INC. 401 K PLAN Strategic Asset Allocation - Optimal Moderate | 3.9% | 6.9% | 7.3% | 5.5% | 7.1% | 5.7% |
VFINX (Vanguard (S&P 500) Index) | -5.7% | 10.8% | 10.3% | 16.0% | 11.9% | 12.6% |
VBINX (Vanguard Balance (60% stocks/40% bonds) | -4.5% | 3.9% | 3.5% | 6.4% | 6.2% | 7.5% |
* YTD: Year to Date
** AR: Annualized Return
** portfolio AR is delayed
Last 1 Week* | 1 Yr | 3 Yr | 5 Yr | 10 Yr | 15 Yr | 15 Yr | 20 Yr | Since 01/02/2001 |
2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Annualized Return(%) | -0.1 | 6.9 | 7.3 | 5.5 | 7.1 | 5.7 | 7.0 | 0.0 | 6.0 | -5.9 | 11.2 | 1.8 | -0.5 | 5.9 | 15.5 | 11.5 | 1.0 | 12.1 | 22.5 | -22.9 | 9.7 | 10.2 | 8.4 | 13.1 | 26.2 | -3.4 | 2.7 |
Sharpe Ratio | NA | -0.22 | 0.07 | 0.12 | 0.49 | NA | NA | NA | 0.39 | -0.22 | 2.27 | 0.21 | -0.06 | 0.85 | 2.15 | 1.57 | 0.07 | 1.03 | 1.24 | -1.11 | 0.71 | 0.88 | 0.96 | 1.56 | 3.01 | -0.43 | 0.04 |
Draw Down(%) | NA | 21.0 | 21.0 | 21.0 | 21.0 | NA | NA | NA | 38.9 | 21.0 | 2.0 | 6.7 | 9.0 | 5.1 | 6.0 | 5.5 | 11.2 | 8.9 | 18.4 | 33.7 | 5.8 | 8.1 | 4.1 | 7.0 | 5.8 | 16.2 | 11.5 |
Standard Deviation(%) | NA | 32.3 | 19.3 | 15.8 | 14.2 | NA | NA | NA | 12.9 | 32.3 | 4.7 | 7.4 | 9.3 | 6.8 | 7.2 | 7.3 | 13.9 | 11.6 | 18.1 | 21.4 | 9.3 | 7.9 | 6.6 | 7.8 | 8.5 | 10.5 | 9.4 |
Treynor Ratio | NA | -0.13 | 0.03 | 0.03 | 0.12 | NA | NA | NA | 0.1 | -0.13 | 0.19 | 0.03 | -0.01 | 0.1 | 0.25 | 0.21 | 0.02 | 0.2 | 0.35 | -0.48 | 0.12 | 0.1 | 0.11 | 0.2 | 0.59 | -0.13 | 0.01 |
Alpha | NA | 0.0 | 0.0 | 0.0 | 0.0 | NA | NA | NA | 0.01 | 0.0 | 0.0 | -0.01 | 0.0 | 0.0 | -0.01 | 0.02 | 0.0 | 0.02 | 0.02 | -0.02 | 0.02 | 0.0 | 0.02 | 0.03 | 0.05 | 0.02 | 0.02 |
Beta | NA | 0.54 | 0.53 | 0.54 | 0.58 | NA | NA | NA | 0.51 | 0.54 | 0.57 | 0.51 | 0.54 | 0.56 | 0.61 | 0.55 | 0.54 | 0.61 | 0.63 | 0.49 | 0.54 | 0.71 | 0.57 | 0.59 | 0.43 | 0.36 | 0.39 |
RSquared | NA | 0.08 | 0.13 | 0.2 | 0.45 | NA | NA | NA | 0.56 | 0.08 | 0.67 | 0.84 | 0.82 | 0.87 | 0.88 | 0.92 | 0.81 | 0.88 | 0.91 | 0.9 | 0.85 | 0.81 | 0.8 | 0.72 | 0.75 | 0.81 | 0.79 |
Sortino Ratio | NA | -0.31 | 0.1 | 0.17 | 0.69 | NA | NA | NA | 0.55 | -0.31 | 3.36 | 0.28 | -0.09 | 1.2 | 3.11 | 2.39 | 0.1 | 1.48 | 1.81 | -1.46 | 0.96 | 1.31 | 1.41 | 2.19 | 4.68 | -0.6 | 0.06 |
Yield(%) | N/A | 2.2 | 1.8 | 2.6 | 4.3 | 4.9 | 4.9 | 5.1 | 3.11 | 2.2 | 0.1 | 2.7 | 5.2 | 2.1 | 3.1 | 3.0 | 3.5 | 2.6 | 2.3 | 2.5 | 5.1 | 4.7 | 3.6 | 3.8 | 3.0 | 2.3 | 4.3 |
Dividend Growth(%) | N/A | 1559.5 | -45.1 | 22.2 | N/A | N/A | N/A | N/A | N/A | 1559.5 | -94.2 | -49.4 | 158.9 | -22.4 | 17.2 | -13.2 | 48.2 | 39.7 | -28.1 | -46.6 | 19.1 | 42.0 | 8.1 | 57.8 | 26.9 | -44.6 | N/A |
*: NOT annualized;YTD: Year to Date
**Inception: starting from 12/31/2000
Portfolio Description
This model portfolio uses Strategic Asset Allocation - Optimal
strategy. Asset weights of available asset classes International Equity, Inflation Protected Bond, US Equity, General Bond, Long Term Bond
in LEXICON PHARMACEUTICALS INC. 401 K PLAN are derived based on long term asset trends and their correlations.
For each major asset class, one or two funds are selected:
1. Risk allocation: the risk profile of this portfolio is 40.
The total allocation of the fixed income asset should be at least 40%.
2. Asset weights:
3. Fund selection: one or two top performing funds among 33 available funds in the plan are chosen for each asset.
They are usually equally weighted within the asset by default. Volatile funds or ETFs with small trading volume are ignored.
4. Rebalance frequency: the portfolio is reviewed by the strategy program monthly
and the above steps are repeated. Asset weights are rebalanced back to target allocation if it is necessary.
5.
Simulation: Performance data before this portfolio went public are obtained from historical simulation. They are hypothetical.
- International Equity
- Inflation Protected Bond
- US Equity
- General Bond
- Long Term Bond
- 19.0%
- 15.0%
- 41.0%
- 20.0%
- 5.0%